Obermatt
See Similar Stocks →

Samyang Biopharm

KSC:0120G0 · KR70120G0001
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book—
Dividend Yield1
Revenue Growth—
Profit Growth—
Capital Growth—
TSR 52w82
Leverage—
Liquidity—
Refinancing—
Combined—
Analyst Opinions—
Pro Holdings38
Opinion Changes—
Market Pulse5

Profile

CountrySouth Korea
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeKOSE
Websitesamyangbiopharm.com
ISINKR70120G0001
Last UpdateApr 2, 2026

Description

Similar Stocks

The companies this stock is ranked against.

Compare Samyang Biopharm with its peers
CSL
ASX:CSL
40
CountryAustralia
IndustryBiotechnology
SizeX-Large
Full Stock Analysis →
Jyong Biotech
NMQ:MENS
—
CountryTaiwan
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Telix Pharmaceuticals
ASX:TLX
30
CountryAustralia
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Panion & Bf Biotech
TAI:1760
84
CountryTaiwan
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Wave Life Sciences
NMQ:WVE
20
CountrySingapore
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Gene One Life Science
KSC:011000
28
CountrySouth Korea
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →